Indian stock markets continue to display a mix of resilience and volatility as bulls attempt to regain control amid challenging trading conditions. Market expert Raja Venkatraman, co-founder of NeoTrader, has identified three promising stocks for traders and investors to consider on 17 November 2025.
Market Context and Trading Outlook
The bulls have been actively working to capitalize on every available opportunity to push markets higher, though their inability to sustain trends at elevated levels has repeatedly dragged indices downward. After extended periods of volatility, the gap scenario has somewhat dampened market enthusiasm. However, selective bullish patterns continue to emerge, capturing investor attention.
On Friday, the Nifty 50 experienced intraday pressure, slipping below the 25,900 mark primarily due to weakness in IT and metal stocks. However, late-session buying helped the index recover partially, closing above 25,900, though the crucial 26,000 level continues to pose significant resistance.
The Sensex demonstrated similar resilience, reversing early losses of nearly 200 points to close 84 points higher at 84,562, supported by gains in select PSU banks and energy counters. The IT sector remained under pressure, reflecting the overnight tech sell-off on Wall Street as the earnings season concluded.
Raja Venkatraman's Top Stock Recommendations
ZOTA Health Care Ltd (Current Price: ₹1,597.10)
Trading Strategy: Buy above ₹1,600 with a stop loss at ₹1,560 and target price of ₹1,690 for multi-day holding.
ZOTA Health Care Ltd specializes in manufacturing and marketing pharmaceutical, nutraceutical, ayurvedic, wellness, and over-the-counter (OTC) products. The stock has demonstrated stability at the KS line and is showing steady volume activity after some deliberation, indicating potential upward movement.
Having established support around ₹1,510, the stock price is gradually trending higher. Key technical indicators show support at ₹1,430 and resistance at ₹1,700. The company currently trades at a P/E ratio of 240.76, with its 52-week high standing at ₹1,627.70 and volume of 98.47 million.
Risk factors include high debt levels, inconsistent profitability patterns, elevated stock valuation, and recent reduction in promoter stake.
SUNPHARMA (Current Price: ₹1,757.10)
Trading Strategy: Buy above ₹1,760 with a stop loss at ₹1,735 and target price of ₹1,810 for intraday trading.
Sun Pharmaceutical Industries has maintained a slow but steady upward trajectory since October without showing signs of weakness. After a period of consolidation, the stock appears poised for further gains. With TS levels holding firm over the past two days, traders can consider long positions at current levels.
The stock shows technical support at ₹1,700 and resistance at ₹1,830. It currently trades at a P/E ratio of 93.66, with its 52-week high at ₹1,910 and volume of 1.73 million.
Key risk considerations include regulatory compliance challenges, intense competition in the pharmaceutical sector, and broader geopolitical uncertainties that could impact international operations.
State Bank of India (SBIN) (Current Price: ₹967.85)
Trading Strategy: Buy above ₹968 with a stop loss at ₹953 and target price of ₹998 for intraday trading.
India's largest public sector bank has experienced a sharp upward movement recently. After a period of consolidation, the stock demonstrated strong momentum on Friday. The rise, following eight days spent at the TS Bands, is generating consistent demand in lower timeframes, making long positions attractive.
Technical analysis indicates support at ₹915 and resistance at ₹1,025. The stock trades at an attractive P/E ratio of 11.93, with its 52-week high at ₹971.15 and volume of 11.03 million.
Potential risks include general market volatility, operational and IT system vulnerabilities inherent in large banking institutions, and broader macroeconomic factors affecting the financial sector.
Market Analysis and Strategic Perspective
The November trading series has proven particularly demanding for market participants, with large-scale volatility leaving both traders and investors feeling the impact. Despite hopeful signs of bullish momentum, markets have remained choppy and uncertain. The current situation remains delicate, and complete recovery appears some distance away.
However, emerging bullish signatures provide some optimism. There has been slight broadening of sector interest as IT stocks joined the upward movement. Since major IT companies represent significant weight in the Nifty index, their participation has provided meaningful support to overall market sentiment.
Nevertheless, sustained interest continues to elude mid-cap and small-cap segments. Despite intermittent bullish spurts, the market may struggle to achieve new highs in the coming week. Recent declines tested support levels before the market ended the week on a relatively strong note, setting the stage for some positive bias in sentiment.
Venkatraman maintains that market dips should be viewed as buying opportunities, recommending investors maintain a bullish bias. The gap region around 25,700 could serve as a support zone for any reactions that might emerge in upcoming trading sessions. For the coming sessions, a clear zone has been defined for long positions, with Nifty looking at 25,700 as a breach of confidence level.
Important Disclaimer: Raja Venkatraman is co-founder of NeoTrader with Sebi-registered research analyst registration number INH000016223. Investments in securities market are subject to market risks. Readers should carefully review all related documents before investing. Registration granted by Sebi and certification from NISM does not guarantee intermediary performance or assure returns to investors. The views and recommendations represent individual analyst opinions and not those of Mint. Investors should consult certified experts before making investment decisions.
